Humana director receives 233 RSUs as equity award
HILZINGER KURT J reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
HILZINGER KURT J reported acquisition or exercise transactions in this Form 4 filing.
Humana Inc. director Kurt J. Hilzinger reported a compensation-related equity award rather than an open-market trade. On June 30, 2026, he received 233 Restricted Stock Units (RSUs) tied to Humana common stock at a reference price of $392.32 per share, classified as a grant or award.
After the reported updates, he directly holds 19,448 shares of Humana common stock and 16,534 RSUs, each representing a contingent right to receive one Humana share on a 1-for-1 basis. Footnotes explain these units arise from annual director fees, cash fee conversions, and dividend reinvestments that have been deferred until he leaves the board.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 233 shares
Grant/Award
4 txns
Insider
HILZINGER KURT J
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 233 | $392.32 | $91K |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Humana Common | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Units — 44,698 contracts for 28,164 underlying shares (Direct);
Humana Common — 19,448 shares (Direct)
Footnotes (3)
- F1. Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.
- F2. Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).
- F3. Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.
Key Figures
RSU grant size: 233 RSUs
RSU reference price: $392.32 per share
Common shares held: 19,448 shares
+3 more
6 metrics
RSU grant size
233 RSUs
Grant of Restricted Stock Units on June 30, 2026
RSU reference price
$392.32 per share
Price per underlying Humana share for the 233 RSU grant
Common shares held
19,448 shares
Humana common stock directly held after reported transactions
RSUs held
16,534 RSUs
Total Restricted Stock Units held after the grant
Underlying RSUs block
3,364 underlying shares
One RSU position in derivative summary with 0.0000 exercise price
Additional RSUs block
24,800 underlying shares
Another RSU position in derivative summary with 0.0000 exercise price
Key Terms
Restricted Stock Units, deferred stock units, Rule 16(b)-3(d)(1), contingent right, +1 more
5 terms
Restricted Stock Units financial
"Restricted Stock Units were granted and held, each tied to Humana common."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
deferred stock units financial
"Director's fee and dividends are converted into deferred stock units."
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
Rule 16(b)-3(d)(1) regulatory
"Annual Director's fee payable in stock units, exempt pursuant to Rule 16(b)-3(d)(1)."
contingent right financial
"Restricted stock units represent a contingent right to receive one share."
2019 Amended & Restated Plan financial
"Units are granted under the Company's 2019 Amended & Restated Plan."
FAQ
What insider transaction did Kurt J. Hilzinger report at Humana (HUM)?
Director Kurt J. Hilzinger reported receiving 233 Restricted Stock Units as a grant tied to Humana common stock. This was a compensation-related award, not an open-market purchase or sale, and is categorized as a grant or other acquisition under Form 4 rules.
How many Restricted Stock Units does Hilzinger hold in Humana (HUM)?
After the reported grant, Hilzinger holds 16,534 Restricted Stock Units linked to Humana common stock. Each RSU represents a contingent right to receive one Humana share, generally payable after his service as a director ends, according to the plan’s terms.
What is the value reference for the 233 Restricted Stock Units granted to Hilzinger?
The 233 Restricted Stock Units were reported with a reference price of $392.32 per underlying Humana share. This price is used for reporting and valuation purposes of the equity award, rather than indicating an open-market trade price on the grant date.
How are Hilzinger’s Humana director fees structured in this Form 4?
Hilzinger’s annual director fees are partly paid in stock units, some from cash fees he elects to convert and dividends reinvested into units. These are deferred until he resigns as a director, when they become payable in Humana common stock on a 1-for-1 basis.
Do the reported Humana (HUM) transactions involve a Rule 10b5-1 trading plan?
The filing describes deferred stock units and grants exempt under Rule 16b-3 but does not reference a Rule 10b5-1 trading plan. The activity reflects compensation elections and dividend reinvestments rather than pre-planned open-market purchases or sales under a trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
